(Q30668704)

26 June 2017

1 reference

title

Optic neuritis after anthrax vaccination (English)

1 reference

26 June 2017

1 reference

1 reference

John B Kerrison

1

1 reference

26 June 2017

David Lounsbury

2

1 reference

26 June 2017

Charles E Thirkill

3

1 reference

26 June 2017

R Gary Lane

4

1 reference

26 June 2017

Martha P Schatz

5

1 reference

26 June 2017

Renata M Engler

6

1 reference

26 June 2017

publication date

1 January 2002

1 reference

26 June 2017

1 reference

26 June 2017

volume

109

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

99-104

1 reference

The specter of biological weapons

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Iraq's biological weapons. The past as future?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Ocular Abnormalities After Influenza Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Development of uveitis following vaccination for influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Uveitis associated with varicella virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Vaccinia keratouveitis manifesting as a masquerade syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Multiple evanescent white dot syndrome after hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Neurological complications of immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Optic neuritis after influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Optic neuritis and myelitis following rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Optic neuritis following measles/rubella vaccination in two 13-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Optic neuritis complicating measles, mumps, and rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Bilateral retrobulbar optic neuritis with hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Spontaneous infection or vaccination as cause of acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Antibodies to human optic nerve in Leber's hereditary optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900844-2

7 January 2021

10.1016/S0161-6420(01)00844-2

Identifiers

DOI

1 reference

26 June 2017

1 reference